Comparison · global CRO & data/analytics provider
An auditable, white-label IQVIA feasibility alternative.
IQVIA is a global CRO and data powerhouse with feasibility and study-planning offerings bundled into broader services. If you want a focused, cited, re-runnable feasibility verdict you control — without buying into a full-service engagement — here is how we compare.
Side by side
IQVIA vs Clinical Trial OS.
The dimensions that decide a feasibility answer, on one row each. Our column is the emphasised one.
| Capability | IQVIA | Clinical Trial OS |
|---|---|---|
| Typical turnaround per protocol | Varies (service-dependent) | Hours |
| Every number cited to a public source | Varies | Yes |
| Same inputs, same verdict — reproducible months later | Varies | Yes |
| 21 CFR Part 11 tamper-evident audit chain on every run | Varies | Yes |
| White-label + dedicated single-tenant cluster | Varies | Yes |
| Private EU-region inference — protocols never used to train a third-party model | Varies | Yes |
| Pricing model | Service / enterprise | Per-run + platform plan |
- Yes
- Varies by engagement
- No
The honest read
What they do well, and what we do differently.
Where IQVIA is strong
IQVIA offers enormous scale, proprietary real-world data assets, and end-to-end clinical services. If you are outsourcing the whole study, that integrated breadth is a genuine strength.
Where we differ
- A focused feasibility verdict you own, delivered in hours and built into your own bid workflow — not a service engagement.
- Full citation provenance on every figure, so the number survives a sponsor challenge.
- Part 11 audit export per run, and a dedicated single-tenant cluster.
- Inference runs in our private EU-region environment; your protocols are never used to train a third-party model, and we never train on your data.
This comparison reflects our understanding of typical offerings and is provided in good faith; vendor capabilities change, so verify current details with each provider. All product names, logos, and trademarks are the property of their respective owners and are used for identification only.
Other comparisons
See a cited verdict against your own protocol.
Send us a protocol — or just a molecule and an indication. We'll return a fully cited feasibility assessment you can trace, line by line, back to public data — yours to defend in a bid, take to your board or investment committee, or hand to a regulator.